This activity is jointly provided by Boston University School of Medicine (BUSM) and Haymarket Medical Education (HME).
Arya Sharma, MD,
Professor of medicine and chair, obesity research and management, University of Alberta, and clinical co-chair, Alberta Health Services Obesity Program, Edmonton, Canada.
Release Date: November 14, 2014
Expiration Date: November 13, 2015
Estimated time to complete the educational activity: 45 minutes
Statement of Need: Because obesity is a disease that frequently occurs as part of a constellation of conditions that increase a patient’s risk for cardiovascular disease, diabetes, and other metabolic conditions, a medical model should be applied to treatment. The initial step in this approach is to evaluate and stage each overweight or obese individual for the presence and severity of obesity-related complications, and the impact of these complications on overall health and well-being. Patients should be counseled on the potential health benefits of losing even a relatively small amount of weight, and educated on the complications and health risks that are remediable by weight loss.
In this activity, a 38-year-old obese female patient presents to her primary care clinician with a number of weight-related comorbidities. Risk-assessment strategies will be explored, as will setting individualized goals for weight reduction via behavioral changes. As many patients fail to attain or maintain a sufficient degree of weight loss with lifestyle changes alone, an overview of available, adjunctive pharmacologic therapies is also provided.
Target Audience: This activity has been designed to meet the educational needs of primary care physicians, endocrinologists, physician assistants, nurse practitioners, nurses, dietitians, and other clinicians with an interest in obesity prevention and management.
Learning Objectives: After completing the activity, the participant should be better able to:
- Stratify overweight and obese patients according to cardiometabolic risks
- Counsel obese patients on evidence-based strategies for weight loss and improvement of weight-related health risks
Physician Credit: This activity has beefign planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine (BUSM) and Haymarket Medical Education. Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation: Boston University School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit: Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly provided by Haymarket Medical Education.
Credit Designation: 0.80 Contact Hours, of which 0.80 is eligible for Pharmacology credit.
Disclosure of Conflicts of Interest
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
The faculty reported the following financial relationships withcommercial interests whose products or services may be mentioned inthis CME/CE activity:
|Name of Faculty||Financial Relationship|
|Arya Sharma, MD||Consultant for NovoNordisk and Takeda. Participant for NovoNordisk, Vivus, and Ethicon’s speaker’s bureaus|
Accredited Provider Disclosures
Kenya Palmer, NP, CNE Course Advisor, Christina Cove, MD, Independent Reviewer, Patti-Ann Collins, DNP, MSN/MBA, RN, Lead Nurse Planner, Emily Jansen, MPH, and Mike Burk, all of Boston University School of Medicine, have no financial relationships to disclose.
Caroline Apovian, MD, BUSM Course Director, is a consultant to Amylin, Arena, Enteromedics, Johnson and Johnson, Merck, Nutrisystem, Orexigen, Sanofi-Aventis, and Zafgen; and has received grant/research funding from Amylin, Aspire Bariatrics, GI Dynamics, Lilly, MetaProteomics, Orexigen, and the Dr. Robert C. and Veronica Atkins Foundation.
Publishing Staff Disclosures
Susan Basilico, Krista Sierra, and Marjorie Hale of Haymarket Medical Education have nothing to disclose with regard to commercial support.
Disclosure of Unlabeled Use: This educational activity contains discussion of approved and/or investigational uses of agents that are not indicated by the FDA. These include: cetilistat, velneperit, tesofensine, and beloranib.
Eisai, Takeda, Orexigen, Boston University, and HME do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Eisai, Takeda, Orexigen, Boston University, and HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Method of Participation: There are no fees for participating in and receiving CME/CE credit for this activity. During the period of November 14, 2014, through November 13, 2015, participants must:
- Read the learning objectives and faculty disclosures;
- Study the educational activity;
- Submit the pre-test and post-test online (clinicians may register at www.mycme.com);
- Complete the evaluation form online
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.
If you have any CME-related questions, please email the BUSM Continuing Medical Education department at: firstname.lastname@example.org.
BUSM Course Code: I.ObeseVLCHME14
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Boston University School of Medicine Disclaimer: THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.